4.7 Article

NFE2L2 and STAT3 Converge on Common Targets to Promote Survival of Primary Lymphoma Cells

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

NRF2 in Cancer: Cross-Talk with Oncogenic Pathways and Involvement in Gammaherpesvirus-Driven Carcinogenesis

Mara Cirone et al.

Summary: Expanding the understanding of the molecular mechanisms in tumor development, especially the interaction between oncogenic pathways, may lead to improved personalized cancer therapies. Nuclear factor erythroid 2-related factor 2 (NRF2) is crucial in cancer progression, not only due to its antioxidant activity but also its cross-talk with several oncogenic pathways. Additionally, NRF2's involvement in gammaherpesvirus-driven carcinogenesis is intriguing, as these viruses utilize the NRF2 pathway to protect tumor cells and avoid excessive reactive oxygen species levels. Manipulating the NRF2 pathway at different stages of gammaherpesvirus-mediated carcinogenesis may have varying outcomes, making it a potential target for cancer therapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

HSPs/STAT3 Interplay Sustains DDR and Promotes Cytokine Release by Primary Effusion Lymphoma Cells

Roberta Gonnella et al.

Summary: This study suggests that targeting HSPs could be an effective strategy to reduce cell survival in primary effusion lymphoma (PEL), as it induces strong DNA damage and impairs DDR. Inhibition of HSPs also results in de-phosphorylation of STAT3, which may downregulate HSPs as well. These findings highlight the importance of targeting HSPs in cancer therapy, as it can reduce cytokine release by PEL cells and affect anti-cancer immune response.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Oncology

NRF2 and STAT3: friends or foes in carcinogenesis?

Andrea Arena et al.

Summary: NRF2 is a transcription factor that plays a critical role in carcinogenesis by interacting with pro-survival pathways. This perspective focuses on the intricate interplay between NRF2 and STAT3, both of which are transcription factors commonly activated in cancer and influence tumor formation and immune suppression. Regulation of NRF2 and STAT3 by ER stress/UPR activation, as well as their interaction with autophagy and cytokines, shape the microenvironment and control DNA damage response. Further investigations into their networking may lead to the discovery of novel strategies to combat cancer more effectively.

DISCOVER ONCOLOGY (2023)

Article Biochemistry & Molecular Biology

The Impact of NRF2 Inhibition on Drug-Induced Colon Cancer Cell Death and p53 Activity: A Pilot Study

Alessia Garufi et al.

Summary: This study investigates the role of NRF2 in cell response to chemotherapeutic drugs in colon cancer cells. The results show that NRF2 activation can protect cells from drug-induced DNA damage and apoptosis, reducing cell death. Furthermore, inhibiting NRF2 pathway can restore p53 activity and enhance the cytotoxic effects of chemotherapy drugs. These findings provide experimental evidence for the inhibition of NRF2 and combination therapies.

BIOMOLECULES (2022)

Review Biochemistry & Molecular Biology

Role of STAT3 and NRF2 in Tumors: Potential Targets for Antitumor Therapy

Yanjun Tian et al.

Summary: This review summarizes the pivotal roles of the two transcription regulators, STAT3 and NRF2, and their interactions in the tumor microenvironment, providing important insights for identifying potential targets for antitumor drugs.

MOLECULES (2022)

Article Biochemistry & Molecular Biology

Mechanisms of Sensitivity and Resistance of Primary Effusion Lymphoma to Dimethyl Fumarate (DMF)

Roberta Gonnella et al.

Summary: This study found that DMF may be a promising drug for the treatment of PEL. It activates NRF2, reduces ROS, inhibits the phosphorylation of STAT3, and suppresses the release of pro-inflammatory and immune suppressive cytokines, thereby inhibiting PEL cell survival. Interestingly, DMF shows a stronger cytotoxic effect on fresh PEL cells compared to PEL cell lines, possibly due to its activation of ERK1/2 and autophagy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Oncology

Targeting Nrf2 may reverse the drug resistance in ovarian cancer

Danjie Li et al.

Summary: Nrf2 plays a crucial role in regulating gene transcription through the Keap1-Nrf2-ARE signaling pathway, protecting cells from oxidative stress and harmful substances. Inhibiting the Nrf2 pathway may reverse drug resistance in ovarian cancer cells.

CANCER CELL INTERNATIONAL (2021)

Review Cell Biology

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky et al.

Summary: The guidelines presented in this article aim to assist researchers in selecting and interpreting methods to examine autophagy, as well as to help reviewers provide constructive critiques of reports focused on these processes. It emphasizes that no single assay is perfect for every situation, and multiple techniques may be needed to properly monitor autophagy in different experimental settings. The article also highlights the importance of targeting multiple autophagy-related genes in genetic approaches to block autophagy effectively.

AUTOPHAGY (2021)

Review Biochemistry & Molecular Biology

LSD1: more than demethylation of histone lysine residues

Bruno Perillo et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2020)

Article Oncology

Involvement of Stat3 phosphorylation in mild heat shock-induced thermotolerance

Masashi Matozaki et al.

EXPERIMENTAL CELL RESEARCH (2019)

Review Biochemistry & Molecular Biology

Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements

Vaishali Aggarwal et al.

BIOMOLECULES (2019)

Review Biochemistry & Molecular Biology

Transcriptional Regulation by Nrf2

Claudia Tonelli et al.

ANTIOXIDANTS & REDOX SIGNALING (2018)

Review Cell Biology

Heat shock proteins and DNA repair mechanisms: an updated overview

Mayra L. Sottile et al.

CELL STRESS & CHAPERONES (2018)

Review Environmental Sciences

Mechanisms of DNA Damage, Repair, and Mutagenesis

Nimrat Chatterjee et al.

ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2017)

Article Biochemistry & Molecular Biology

Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K/AKT/mTOR and STAT3 signaling pathways

Marisa Granato et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2017)

Review Physiology

mTOR as a Key Regulator in Maintaining Skeletal Muscle Mass

Mee-Sup Yoon

FRONTIERS IN PHYSIOLOGY (2017)

Review Biochemistry & Molecular Biology

Opportunities and challenges provided by crosstalk between signalling pathways in cancer

A. Prahallad et al.

ONCOGENE (2016)

Article Biochemical Research Methods

Combenefit: an interactive platform for the analysis and visualization of drug combinations

Giovanni Y. Di Veroli et al.

BIOINFORMATICS (2016)

Review Cell Biology

The role of STAT3 in autophagy

Liangkun You et al.

AUTOPHAGY (2015)

Article Biochemistry & Molecular Biology

p62 links autophagy and Nrf2 signaling

Tao Jiang et al.

FREE RADICAL BIOLOGY AND MEDICINE (2015)

Review Pharmacology & Pharmacy

Transcription factors Hsf1 and Nrf2 engage in crosstalk for cytoprotection

Sharadha Dayalan Naidu et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2015)

Article Multidisciplinary Sciences

STAT3 activation by KSHV correlates with IL-10, IL-6 and IL-23 release and an autophagic block in dendritic cells

Roberta Santarelli et al.

SCIENTIFIC REPORTS (2014)

Review Oncology

STAT3 Target Genes Relevant to Human Cancers

Richard L. Carpenter et al.

CANCERS (2014)

Review Oncology

Targeting heat shock proteins in cancer

Gaetan Jego et al.

CANCER LETTERS (2013)

Article Cell Biology

Contribution of viral and cellular cytokines to Kaposi's sarcoma-associated herpesvirus pathogenesis

Paola Gasperini et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2008)